Identity
- Security key
- 16838
- Ticker
- IBO
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-09-16
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- IBO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $48,196,090.26
- Shares outstanding (class)
- 107,821,231
- Shares outstanding (weighted)
- 107,821,231
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 8
- Location
- HOUSTON, TX
- Homepage
- https://www.impactbiomedinc.com
- Description
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.